Dabigatran, rivaroxaban, or apixaban versus enoxaparin for thromboprophylaxis after total hip or knee replacement: systematic review, meta-analysis, and indirect treatment comparis...

Por Gómez-Outes, Antonio, Terleira-Fernández, Ana Isabel, Suárez-Gea, M Luisa, Vargas-Castrillón, Emilio
Publicado em 2012

Direct oral anticoagulants in the treatment of venous thromboembolism, with a focus on patients with pulmonary embolism: an evidence-based review

Por Gómez-Outes, Antonio, Suárez-Gea, Mª Luisa, Lecumberri, Ramón, Terleira-Fernández, Ana Isabel, Vargas-Castrillón, Emilio
Publicado no Vasc Health Risk Manag (2014)

Dabigatran, Rivaroxaban, or Apixaban versus Warfarin in Patients with Nonvalvular Atrial Fibrillation: A Systematic Review and Meta-Analysis of Subgroups

Por Gómez-Outes, Antonio, Terleira-Fernández, Ana Isabel, Calvo-Rojas, Gonzalo, Suárez-Gea, M. Luisa, Vargas-Castrillón, Emilio
Publicado em 2013

Direct oral anticoagulants for stroke prevention in patients with atrial fibrillation: meta‐analysis by geographic region with a focus on European patients

Por Gómez‐Outes, Antonio, Terleira‐Fernández, Ana‐Isabel, Calvo‐Rojas, Gonzalo, Suárez‐Gea, M. Luisa, Vargas‐Castrillón, Emilio
Publicado no Br J Clin Pharmacol (2016)

Potential role of new anticoagulants for prevention and treatment of venous thromboembolism in cancer patients

Por Gómez-Outes, Antonio, Suárez-Gea, M Luisa, Lecumberri, Ramón, Terleira-Fernández, Ana Isabel, Vargas-Castrillón, Emilio, Rocha, Eduardo
Publicado em 2013

Modificación en el patrón de uso de anfotericina B no convencional tras la puesta en marcha de una intervención formativa en el Hospital Clínico San Carlos de Madrid

Por Prieto Yerro Concepción, Laredo Velasco Leonor, Rodríguez Bernardino Ángel, Vargas Castrillón Emilio, Ambit Ávila MI M.ª Isabel, Merchante Medina Alfonso
Publicado em 2001-01-01